Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Vaccines

Free Subscription Articles published in Arch Virol Retrieve available abstracts of 15 articles: HTML format

Single Articles

October 2025
1. RYU NG, Yang YJ, Kim KI
   Application of a multi-epitope DNA vaccine against viral hemorrhagic septicemia virus type ?a.
   Arch Virol. 2025;170:222.
   PubMed    
   
   
   September 2025
2. CUI X, Wang S, Han Q, Jin N, et al
   Molecular characterization of infectious laryngotracheitis virus in China and host transcriptomic responses to immunization with a live attenuated vaccine.
   Arch Virol. 2025;170:216.
   PubMed     Abstract available
   
   
   August 2025
3. ZADEH MEHRIZI T, Eshrati B, Ebrahimi Shahmabadi H
   Evaluation of recent pre-booster studies on hepatitis B vaccine effectiveness across WHO regions with HBV prevalence above 1% in the general population up to 60 years of age: a systematic review.
   Arch Virol. 2025;170:193.
   PubMed    
   
   
   July 2025
4. NEMOTO M, Kawanishi N, Kambayashi Y, Bannai H, et al
   Growth properties of recombinant equine influenza viruses with different backbones generated by reverse genetics in embryonated chicken eggs.
   Arch Virol. 2025;170:181.
   PubMed     Abstract available
   
   
   June 2025
5. MULONDO G, Buyse MLR, Labuschagne K, Jarvis D, et al
   Production and immunogenicity of a plant-produced beak and feather disease virus vaccine in Japanese quails.
   Arch Virol. 2025;170:163.
   PubMed     Abstract available
   
   
   May 2025
6. CHEN T, Xu W, Duan P, Jiang S, et al
   MF59-like adjuvant containing yeast-derived squalene enhances the humoral immune response to cell-derived influenza vaccine.
   Arch Virol. 2025;170:134.
   PubMed     Abstract available
   
   
   March 2025
7. YE QY, Jiang ZT, Jiang Y, Cai JW, et al
   Effectiveness of inactivated COVID-19 vaccine against symptom severity in hospitalized COVID-19 patients infected with the Omicron variant.
   Arch Virol. 2025;170:88.
   PubMed     Abstract available
   
   
   February 2025
8. KOTHARI D, Patel N, Bishoyi AK
   Dengue: epidemiology, diagnosis methods, treatment options, and prevention strategies.
   Arch Virol. 2025;170:48.
   PubMed     Abstract available
   
   
   January 2025
9. ASHRAF MA, Raza MA, Imran A, Amjad MN, et al
   Next-generation vaccines for influenza B virus: advancements and challenges.
   Arch Virol. 2025;170:25.
   PubMed     Abstract available
   
   
   December 2024
10. SORDO-PUGA Y, Santana-Rodriguez E, Perez-Perez D, Mendez-Orta MK, et al
    Porvac((R)) subunit vaccine induces neutralizing antibodies against all three main classical swine fever virus genotypes.
    Arch Virol. 2024;170:22.
    PubMed     Abstract available
    
    
    
11. OLORUNTIMEHIN ES, Volodina SI, Patraman IV, Nadtochey GA, et al
    Molecular and ultrastructural characteristics of virulent and attenuated vaccine strains of goose parvovirus LIV-22.
    Arch Virol. 2024;170:4.
    PubMed     Abstract available
    
    
    July 2024
12. LIU C, Li S, Qiao M, Zeng C, et al
    GB and gH/gL fusion machinery: a promising target for vaccines to prevent Epstein-Barr virus infection.
    Arch Virol. 2024;169:167.
    PubMed     Abstract available
    
    
    
13. LUO J, Zhang M, Ye Q, Gao F, et al
    A synthetic TLR4 agonist significantly increases humoral immune responses and the protective ability of an MDCK-cell-derived inactivated H7N9 vaccine in mice.
    Arch Virol. 2024;169:163.
    PubMed     Abstract available
    
    
    April 2024
14. ALVAREZ-QUINTO R, Grinstead S, Kinard G, Martin R, et al
    Complete genome sequence of vaccinium-associated virus C, a new member of the family Totiviridae from Vaccinium floribundum.
    Arch Virol. 2024;169:86.
    PubMed     Abstract available
    
    
    March 2024
15. LATIFI T, Kachooei A, Jalilvand S, Zafarian S, et al
    Correlates of immune protection against human rotaviruses: natural infection and vaccination.
    Arch Virol. 2024;169:72.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.